Virtual: Multimodal Management of Canine Degenerative Joint Disease

Virtual: Multimodal Management of Canine Degenerative Joint Disease

Saturday, January 17, 2026 5:00 PM to 5:50 PM · 50 min. (America/New_York)
Scheduled - Virtual
Lameness

Information

This session discusses the diagnosis and non-surgical management of canine degenerative joint disease. Multimodal management and other treatment options will be discussed. Surgical management is only briefly discussed. This session is for all small animal practitioners who see arthritic canine patients in their practice.
Program
Virtual: Nutramax Laboratories Symposium
CE Credit
1
Primary Discipline
Small Animal
Learning Level
Intermediate
On-Demand
Converts to On-Demand
RACE Credit Type
Medical
Nutramax Laboratories Veterinary Sciences Inc.2605Since its inception, Nutramax Laboratories has researched, developed, and manufactured products that improve the quality of life for people and their pets. We have become an industry leader in setting and adhering to high standards in manufacturing and quality control, while continuously conducting and supporting laboratory research and clinical studies on our products. Our quality standard includes rigorous testing and inspection at every stage of the production process. We are committed to the highest-quality products, manufactured in state-of-the-art facilities. Among our vast product portfolio, are COSEQUIN® and DASUQUIN® joint health supplements, DENAMARIN® for liver support, PROVIABLE® for digestive health, SOLLIQUIN® for behavioral health, and WELACTIN® for skin/coat health. Nutramax Laboratories is headquartered in Lancaster, SC and employs more than 700 people nationwide. To learn more, visit: http://www.nutramaxlabs.com

Registered attendees

Michael Jaffe
Michael Jaffe
Associate Professor of Small Animal SurgeryMississippi State University

Join the event!

See all the content and easy-to-use features by logging in or registering!